The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

Vaccine

Volumn 18, Issue 9-10, 1999, Pages 850-859

  Solioz, Nathaly ^a   Blum Tirouvanziam, Usha ^a   Jacquet, Raymond ^a   Rafati, Sima ^b   Corradin, Giampietro ^a   Mauël, Jacques ^a   Fasel, Nicolas ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Histone H1; Leishmania major; Vaccine

Indexed keywords

HISTONE H1; LEISHMANIA VACCINE; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; FEMALE; HISTONES; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTOZOAN PROTEINS; VACCINES, SYNTHETIC;

EID: 0032704475     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00340-0     Document Type: Article

References (36)

1. Gramiccia M., Gradoni L., Troiani M. HIV-Leishmania co-infections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients. Transactions of the Royal Society of Tropical Medicine & Hygiene. 86:1992;161.
2. Locksley R.M., Louis J.A. Immunology of leishmaniasis. Curr. Opin. Immunol. 4:1992;413.
3. Locksley R.M., Scott P. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol. Today. 12:1991;158.
4. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Ann. Rev. Immunol. 13:1995;151.
5. Romagnani S. Th1 and Th2 in human diseases. Clin. Immunol. & Immunopathol. 80:1996;225.
6. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., Murphy K.M. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547.
7. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive transfer immunity. Ann. Rev. Immunol. 13:1995;251.
8. O'Garra A., Murphy K. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:1994;458.
9. Cooper A.M., Roberts A.D., Rhoades E.R., Callahan J.E., Getzy D.M., Orme I.M. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology. 84:1995;423.
10. Gazzinelli R.T., Wysocka M., Hayasi S., Denkers E.Y., Hieny S., Caspar P., Trinchieri G., Sher A. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:1994;2533.
11. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., Gately M.K. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1993;1505.
12. Tripp C.S., Wolf W.F., Unanue E.R. Interleukin-12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin-10 is a physiologic agonist. Proc. Natl. Acad. Sci. USA. 90:1993;3725.
13. Afonso L.C.C., Sharton T.M., Vieira L.Q., Wysocka M., Trinchieri G., Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science. 263:1994;235.
14. Miller M.A., Skeen M.J., Ziegler H.K. Nonviable bacterial antigens administrated with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155:1995;4817.
15. Handman E. Leishmania vaccines: old and new. Parasitol Today. 13:1997;236.
16. Handman E., Mitchell G.F. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc. Natl. Acad. Sci. USA. 82:1985;5910.
17. Russel D.G., Alexander J. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140:1988;1274.
18. Yang D.M., Fairweather N., Button L.L., McMaster W.R., Kahl L.P., Liew F.Y. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells ans protective immunity against leishmaniasis. J. Immunol. 145:1990;2281.
19. McMahon-Pratt D., Rodriguez D., Rodriguez J.R., Zhang Y., Manson K., Bergman C., Rivas L., Rodriguez J.F., Lohman K.L., Ruddle N.H., Esteban M. Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. Infect. Immun. 61:1993;3351.
20. Scott P., Pearce E., Natovitz P., Sher A. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139:1987;221.
21. Mougneau E., Altare F., Walkil A.E., Zheng S., Coppola T., Wang Z., Waldmann R., Locksley R.M., Glaichenhaus N. Expression cloning of a protective Leishmania antigen. Science. 268:1995;563.
22. Xu D., Liew F.Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein gp63 of Leishmania major. Immunology. 84:1995;173.
23. Walkers P.S., Scharton-Kersten T., Rowton E.D., Hengge U., Bouloc A., Udey M.C., Vogel J.C. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type-1 immune response and protection in a murine model of leishmaniasis. Human Gene Therapy. 9:1998;1899.
24. Gurunathan S., Prussin C., Sacks D.L., Seder R.A. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nature Medicine. 4:1998;1409.
25. Gurunathan S., Sacks D.L., Brown D.R., Reiner S.L., Charest H., Glaichenhaus N., Seder R.A. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers immunity to mice infected with Leishmania major. J. Exp. Med. 186:1997;1137.
26. Fasel N.J., Robyr D.C., Mauel J., Glaser T.A. Identification of histone H1-like gene expressed in Leishmania major. Molel. Biochem. Parasitol. 62:1994;321.
27. Noll T., Desponds C., Belli S.I., Glaser T.A., Fasel N.J. Histone H1 expression varies during the Leishmania major life-cycle. Molel. Biochem. Parasitol. 84:1997;215.
28. Louis J., Moeder E., Behin R., Engers H. Recognition of protozoan parasite antigens by murine T lymphocytes. I. Induction of specific T lymphocyte-dependent proliferative response to Leishmania tropica. Eur. J. Immunol. 9:1979;841.
29. Belli S., Formenton A., Noll T., Ivens A., Jacquet R., Desponds C., Fasel N. Leishmania major: Histone H1 gene expression from the sw3 locus. Experimental Parasitology. 91:1999;151.
30. Merrifield R.B. Solid phase synthesis. Science. 232:1986;341.
31. Atherton E., Logan C.J., Shepard R.C. Peptide syntesis. Part II. Procedures for solid phase synthesis using Na-fluorenylmethoxycarbamylamino acids on polyamine supports: synthesis of substance P and acyl carrier protein 65-74 decapeptide. J. Chem. Soc. (London). 1:1988;538.
32. Roggero M.A., Servis C., Corradin G. A simple procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry. FEBS Letters. 408:1997;285.
33. Sanders C. A method for the fractionation of the high-mobility-non-histone chromosomal proteins. Biochem & Biophys Res Communications. 78:1977;1034.
34. Handman E., Symons F.M., Baldwin T.M., Curtis J.M., Scheerlinck J-P.Y. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response. Infection and Immunity. 63:1995;4261-4267.
35. Skeiky Y.A., Kennedy M., Kaufman D., Borges M.M., Guderian J.A., Scholler J.K., Ovendale P.J., Picha K.S., Morrissey P.J., Grabstein K.H., Campos-Neto A., Reed S.G. LeIF: a recombinant Leishmania protein that induces an IL-12 mediated Th1 cytokine profile. J. Immunol. 161:1998;6171.
36. Jankovic D., Caspar P., Zweig M., Garcia-Moll M., Showalter S.D., Vogel F., Sher A. Adsorption to aluminium hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type-1 cytokine responses to HIV-1 gp 120. J. Immunol. 159:1997;2409.